These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3325717)

  • 21. Preclinical and early clinical trial with mafosfamide as immune modulator.
    Klein HO; Kreysch HG; Coerper C; Voigt P; Ruff I
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):627-40. PubMed ID: 3325719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells.
    Askenase PW; Szczepanik M; Ptak M; Paliwal V; Ptak W
    J Immunol; 1995 Apr; 154(8):3644-53. PubMed ID: 7706708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.
    Yu B; Kusmartsev S; Cheng F; Paolini M; Nefedova Y; Sotomayor E; Gabrilovich D
    Clin Cancer Res; 2003 Jan; 9(1):285-94. PubMed ID: 12538481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of lethal and cytostatic effects of alkylnitrosoureas on the cells of experimental tumors.
    Emanuel NM; Ostrovskaya LA; Krutova TV; Konradov AA
    Neoplasma; 1984; 31(5):529-38. PubMed ID: 6504211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of antitumor response by in vivo allogeneic major histocompatibility complex gene transfer using electroporation.
    Shimizu H; Nukui Y; Mitsuhashi N; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Miyazaki M
    J Surg Res; 2009 Jun; 154(1):60-7. PubMed ID: 19101693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.
    Pawlik TM; Nakamura H; Mullen JT; Kasuya H; Yoon SS; Chandrasekhar S; Chiocca EA; Tanabe KK
    Cancer; 2002 Sep; 95(5):1171-81. PubMed ID: 12209705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MOPC-315 tumor as a model for the immunomodulatory effects of cyclophosphamide.
    Mokyr MB
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):579-88. PubMed ID: 3325714
    [No Abstract]   [Full Text] [Related]  

  • 34. Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy.
    van de Ven R; Reurs AW; Wijnands PGJTB; van Wetering S; Kruisbeek AM; Hooijberg E; Scheffer GL; Scheper RJ; de Gruijl TD
    Cancer Immunol Immunother; 2012 Feb; 61(2):181-191. PubMed ID: 21874304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
    Scheper RJ; Limpens J; Tan BT; Valster H; Claessen AM; Claessen ME
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):611-5. PubMed ID: 3325717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
    Claessen AM; Valster H; Bril H; Steerenberg PA; Tan BT; Scheper RJ
    Int J Cancer; 1991 Feb; 47(4):626-32. PubMed ID: 1995491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disillusionments and hopes in the field of biological response modifiers.
    Tanneberger S; Pannuti F
    Anticancer Res; 1993; 13(1):185-92. PubMed ID: 8476212
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.